Clinical trials
Squamous Intraepithelial Lesions trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
92 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2004 | 1 |
| 2006 | 2 |
| 2007 | 7 |
| 2008 | 1 |
| 2009 | 1 |
| 2010 | 2 |
| 2011 | 1 |
| 2013 | 1 |
| 2014 | 3 |
| 2015 | 5 |
| 2016 | 4 |
| 2017 | 3 |
| 2018 | 7 |
| 2019 | 6 |
| 2020 | 4 |
| 2021 | 6 |
| 2022 | 4 |
| 2023 | 5 |
| 2024 | 10 |
| 2025 | 4 |
| 2026 | 11 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 39 |
| Unknown status | 22 |
| Recruiting | 14 |
| Not yet recruiting | 8 |
| Terminated | 5 |
| Active, not recruiting | 3 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AIDS Malignancy Consortium | 8 |
| Fujian Maternity and Child Health Hospital | 5 |
| Antiva Biosciences | 4 |
| Lei Li | 4 |
| Inovio Pharmaceuticals | 3 |
| Newish Biotech (Wuxi) Co., Ltd. | 3 |
| National Cancer Institute (NCI) | 2 |
| Peking University People's Hospital | 2 |
| Second Affiliated Hospital, Zhejiang University, School of Medicine | 2 |
| The Center for Clinical and Cosmetic Research | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Squamous Intraepithelial Lesions | 92 |
| Uterine Cervical Dysplasia | 25 |
| Papillomavirus Infections | 24 |
| Uterine Cervical Neoplasms | 17 |
| Anus Neoplasms | 12 |
| Atypical Squamous Cells of the Cervix | 11 |
| Precancerous Conditions | 8 |
| Carcinoma, Squamous Cell | 7 |
| Acquired Immunodeficiency Syndrome | 6 |
| Bowen's Disease | 6 |
Trials
Showing 51 to 75 of 92. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.